The results of data mining showed that among 5 ALK-TKIs, crizotinib and lorlatinib presented a higher risk of cardiotoxicity, with HLGT involved mainly in heart failure, pericardial disorders, myocardial disorders, and arrhythmia. This evidence concerns the gene ALK and myocardial disorder.